Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on X:
“A most brilliant time, spending a few quality moments with Professor Charlie Craddock at ASH25, discussing the importance of clinical trial networks across the world for rare blood cancers!”
More posts featuring Naveen Pemmaraju.